» Articles » PMID: 19376489

The Association Between Birthweight 4000 G or Greater and Perinatal Outcomes in Patients with and Without Gestational Diabetes Mellitus

Overview
Publisher Elsevier
Date 2009 Apr 21
PMID 19376489
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of the study was to examine the association between birthweight of 4000 g or greater and perinatal outcomes in women with and without gestational diabetes mellitus (GDM).

Study Design: This was a retrospective cohort study of 36,241 singleton pregnancies stratified by the diagnosis of GDM, with presence or absence of birthweight of 4000 g or greater. Outcomes examined included neonatal hyperbilirubinemia, hypoglycemia, respiratory distress syndrome (RDS), shoulder dystocia, and Erb's palsy. chi(2) tests and multivariable logistic regression analyses were used to control for confounders.

Results: In women with GDM, neonates with a birthweight of 4000 g or greater, compared with those with a birthweight of less than 4000 g, had higher frequencies of hypoglycemia (5.3% vs 2.6%; P = .04), RDS (4.0% vs 1.5%; P = .03), shoulder dystocia (10.5% vs 1.6%; P < .001), and Erb's palsy (2.6% vs 0.2%; P < .001). Even without GDM, these outcomes occurred more frequently in infants with birthweight of 4000 g or greater. GDM increases the odds of adverse outcomes associated with birthweight of 4000 g or greater, particularly shoulder dystocia (adjusted odds ratios [aORs], 16.4 [GDM] vs 9.6 [non-GDM] and Erb's palsy (aORs, 41.9 [GDM] vs 6.7 [non-GDM]).

Conclusion: Birthweight of 4000 g or greater is associated with a higher incidence of adverse perinatal outcomes such that neonatal providers should be alerted.

Citing Articles

Loss of RIP3 alleviates insulin resistance and inflammation in gestational diabetes mellitus mice via TLR4/MyD88/NF-κB signaling pathway.

He Y, Zhu W, Qiu Y, Zhou K BMC Pregnancy Childbirth. 2025; 25(1):163.

PMID: 39953423 PMC: 11829474. DOI: 10.1186/s12884-025-07217-8.


Machine learning approaches for predicting fetal macrosomia at different stages of pregnancy: a retrospective study in China.

Liu Q, Zhu S, Zhao M, Ma L, Wang C, Sun X BMC Pregnancy Childbirth. 2025; 25(1):140.

PMID: 39934718 PMC: 11817776. DOI: 10.1186/s12884-025-07239-2.


Prevalence of macrosomic newborn and maternal and neonatal complications in a high-risk maternity.

Sousa K, Leite H, Dias Correa M, Sousa M, Queiroz A Rev Bras Ginecol Obstet. 2024; 46.

PMID: 38994466 PMC: 11239214. DOI: 10.61622/rbgo/2024rbgo48.


Birthweight trends and their explanatory factors in Hungary between 1999 and 2018: an analysis of the Hungarian Tauffer registry.

Zsirai L, Kun A, Visolyi G, Svebis M, Domjan B, Tabak A Reprod Health. 2024; 21(1):52.

PMID: 38609984 PMC: 11015640. DOI: 10.1186/s12978-024-01787-0.


Protein Profiling of Placental Extracellular Vesicles in Gestational Diabetes Mellitus.

Kandzija N, Payne S, Cooke W, Seedat F, Fischer R, Vatish M Int J Mol Sci. 2024; 25(4).

PMID: 38396626 PMC: 10887986. DOI: 10.3390/ijms25041947.